HFGB signs another $600,000 worth of orders.
Huifeng Bio-Pharmaceutical (HFGB) Announces Participation in the 59th PHARMCHINA Expo
XI'AN, China, April 18, 2008 /Xinhua-PRNewswire-FirstCall via COMTEX/ -- Huifeng Bio- Pharmaceutical Technology, Inc.(HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today announced that it participated in the 59th biannual PHARMCHINA Expo held in Xi'an, China from April 15-17.
With an exhibition area of 45,000 sq. meters, attracting over 1,500 exhibitors and 100,000 professionals, PHARMCHINA (the China National Pharmaceuticals Fair) is the largest pharmaceutical fair in China. Held twice a year, with a history of nearly 30 years, it has become a can't miss event for all professionals interested in Traditional Chinese Medicine, Neutraceuticals and Pharmaceuticals in the People's Republic of China.
While at the conference, Huifeng is pleased to announce the signing of contracts with three new customers for its main products of Rutin, Troxerutin and Quercetin. The total value of these contracts is estimated at $600,000 in 2008.
About Huifeng Bio-Pharmaceutical Technology, Inc. (HFGB)
Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi'an, People's Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. hfgb.cn
For more information, please contact:
Dan Carlson
Primary Capital LLC
Email: DCarlson@PrimaryLLC.com |
